Its expression in GBM tumors is upregulated by hypoxia [23] and EGFR activation [147,148] as well as the action of epidermal growth factor receptor variant III (EGFRvIII) [147] and hepatocyte growth factor (HGF) [149]. This evidence concerns the gene EGFR and glioblastoma.